Skip to main content
Premium Trial:

Request an Annual Quote

HTG Files $75M Shelf Registration

NEW YORK (GenomeWeb) – HTG Molecular yesterday filed a shelf registration to publicly offer up to $75 million of its common stock, according to a filing with the US Securities and Exchange Commission.

Proceeds from the sale of the stock will be used for working capital and general corporate purposes such as capital expenditures, debt repayment, research and development, sales and marketing, and administrative expenses, the company said in the filing. It may also use a portion of the proceeds to acquire or invest in businesses, products, and technologies complementary to its own, although it has no current plans to do so.

Earlier this month, HTG reported finishing 2016 with $7.5 million in cash and cash equivalents, and $4.3 million in short-term investments available for sale. In a separate filing with the SEC yesterday, the firm noted that the average monthly net cash used during the fourth quarter of 2016 was $1.6 million.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.